Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
Annals of the Rheumatic Diseases · 2024
DOI: 10.1136/ard-2023-225014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2024. Verfasst von Joshua F Baker und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania, Philadelphia, Pennsylvania, USA joshua.baker@pennmedicine.upenn.edu. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, BLRD VA, CSRD VA.
Abstract (Originalsprache)
PURPOSE: To determine if body mass index (BMI) and adipokine levels identify rheumatoid arthritis (RA) patients most likely to benefit from initiation of tumour necrosis factor inhibitors (TNFi) after methotrexate inadequate response. METHODS: This is a secondary analysis of the Rheumatoid Arthritis Comparison of Active Treatments (RACAT) trial and the (TEAR) trial. Both studies compared treatment strategies starting with conventional disease-modifying anti-rheumatic drugs (DMARDs) (triple therapy) versus etanercept plus methotrexate. We compared response rates between TNFi and triple therapy among patients with different BMI. Adipokines were measured at enrolment and associations with treatment response were examined using regression, adjusting for age, sex, BMI and baseline disease activity. RESULTS: In RACAT (n=306), participants who were normal/underweight were more likely to benefit from TNFi versus triple therapy, with greater change in Disease Activity Score in 28 and greater ACR20 response (ACR 20: 64% vs 23%, p=0.001). In contrast, overweight/obese participants had similar response to TNFi versus triple therapy (p-for-interaction=0.001). Similarly, but modest patterns were observed in TEAR (n=601; ACR20: 67% vs 52%, p=0.05). In RACAT, adipokine scores consistent with lower adiposity also predicted greater response to TNFi (ACR20: 58% vs 37%, p=0.01) with better model fit compared with BMI alone. CONCLUSIONS: Lower BMI and evidence of lower adiposity based on adipokine profiles were associated with a superior response to TNFi compared with triple therapy. There was no difference between treatments among overweight/obese participants. The results support TNFi being a particularly important therapeutic among normal/underweight patients, with implications for clinical decisions and trial design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Pennsylvania, Philadelphia, Pennsylvania, USA joshua.baker@pennmedicine.upenn.edu.
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Rheumatology, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
- Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
Förderung
- NIAMS NIH HHS
- BLRD VA
- CSRD VA
- RRD VA
- NIGMS NIH HHS
- Department of Defense
- NIAMS
- National Institutes of General Medical Sciences
Zitieren
APA
Baker, J. F., ODell, J. R., England, B. R., Giles, J. T., Newcomb, J. A., George, M. D., Thiele, G., Moreland, L., Bridges, S. L., Curtis, J. R., & Mikuls, T. R. (2024). Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2023-225014
Vancouver
Baker JF, ODell JR, England BR, Giles JT, Newcomb JA, George MD, et al. Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis. Annals of the Rheumatic Diseases. 2024. doi:10.1136/ard-2023-225014
BibTeX
@article{Baker2024,
author = {Baker, Joshua F and ODell, James R and England, Bryant R and Giles, Jon T and Newcomb, Jefferey A and George, Michael D and Thiele, Geoffrey and Moreland, Larry and Bridges, S Louis and Curtis, Jeffrey R and Mikuls, Ted R},
title = {Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2024},
doi = {10.1136/ard-2023-225014}
}
EUVIMED